Oral anti-ulcer activity of a synthetic prostaglandin analogue (9-oxoprostanoic acid: AY-22,469).
D000284:Administration, Oral; D000818:Animals; D002264:Carboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D003080:Cold Temperature; D003517:Cyclopentanes / Q000008:administration & dosage / Q000494:pharmacology; D007099:Imipramine / Q000008:administration & dosage / Q000494:pharmacology; D007103:Immobilization; D007274:Injections, Intraperitoneal; D008026:Ligation; D008297:Male; D010437:Peptic Ulcer / Q000139:chemically induced / Q000209:etiology / Q000517:prevention & control*; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D011708:Pylorus; D051381:Rats; D012110:Reserpine; D013312:Stress, Physiological
D002264:Carboxylic Acids; D003517:Cyclopentanes; D011453:Prostaglandins; D012110:Reserpine; D007099:Imipramine